Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Vertex Pharmaceuticals Incorporated    VRTX   US92532F1003

Delayed Quote. Delayed Nasdaq - 10/31 04:00:00 pm
112.64 USD   +1.61%
1d ago VERTEX PHARMACEUTICALS : to Present at the Credit Suisse Healthcare Confere..
2d ago NASDAQ 100 MOVERS : Fb, wdc
3d ago VERTEX PHARMACEUTICALS : tops Street 3Q forecasts
 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
10/27/2014 10/28/2014 10/29/2014 10/30/2014 10/31/2014 Date
111.59(c) 114.07(c) 109.91(c) 110.85(c) 112.64 Last
1 204 972 2 170 562 2 449 051 1 398 361 1 664 600 Volume
+1.53% +2.22% -3.65% +0.86% +1.61% Change
More quotes
Company
Vertex Pharmaceuticals, Inc. is engaged in the business of discovering, developing, manufacturing and commercializing small molecule drugs.The company's research focuses on cystic fibrosis; infectious diseases, including viral infections, such as influenza, and bacterial infections; autoimmune... 
Sector
Pharmaceuticals
Calendar
11/11 | 01:00pmPresentation
Surperformance© rating of Vertex Pharmaceuticals Inc
Trading Rating : Investor Rating :
More about the company
Chart VERTEX PHARMACEUTICALS INC
Duration : Period :
Vertex Pharmaceuticals Inc Technical Analysis Chart | VRTX | US92532F1003 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 567 M
EBIT 2014 -657 M
Net income 2014 -718 M
Finance 2014 435 M
Yield 2014 -
Sales 2015 1 307 M
EBIT 2015 -7,30 M
Net income 2015 -111 M
Finance 2015 797 M
Yield 2015 -
PER 2014 -
PER 2015
EV / Sales 2014 45,8x
EV / Sales 2015 19,6x
Capitalization 26 391 M
More Financials
Latest news on VERTEX PHARMACEUTICALS INC
1d ago VERTEX PHARMACEUTICALS : to Present at the Credit Suisse Healthcare Conference o..
1d ago VERTEX PHARMACEUTICALS : Aileron Therapeutics Expands Senior Management Team
2d ago VERTEX PHARMACEUTICALS : FDA Advisory Committee Recommends Approval of KALYDECO®..
2d ago VERTEX PHARMACEUTICALS : Patent Issued for Thiazoles, Imidazoles, and Pyrazoles ..
2d ago NASDAQ 100 MOVERS : Fb, wdc
3d ago VERTEX PHARMACEUTICALS : tops Street 3Q forecasts
3d ago VERTEX PHARMACEUTICALS : Reports Third Quarter 2014 Financial Results
3d ago VERTEX PHARMACEUTICALS : Assigned Patent
10/23 VERTEX PHARMACEUTICALS : to Announce Third Quarter 2014 Financial Results on Oct..
10/22DJU.S. HOT STOCKS : Hot Stocks to Watch
10/21 VERTEX PHARMACEUTICALS : FDA Advisory Committee Recommends Approval of KALYDECO®..
10/20 VERTEX PHARMACEUTICALS : Health and Human Services Department (HHS); Food and Dr..
More news


Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF